NKTR Nektar Therapeutics Loading...

Loading chart...
Top Calls

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
16:37
Oct 20
crux_capital_
Best performer in broad portfolio
Holds $NKTR as one of today's best performers in a broad portfolio, saying diversification makes volatility easier to stomach.
NKTR Nektar Therapeutics Long 1ST Position: Holding —
17:10
Oct 01
A May MD
$NKTR data positive, market assigns no value
Author, a clinician who treats the disease, reads $NKTR's new data as an incremental positive—dosing flexibility where current options lack it—while the market assigned the indication no value coming into the print.
NKTR Nektar Therapeutics Long — —
15:03
Oct 01
seedy19tron
NKTR long-term recovery despite retail-heavy base
Author expects NKTR to recover over the long term, arguing heavy retail ownership and the absence of major specialist buyers leaves the stock unsupported on down days but does not impair eventual recovery.
NKTR Nektar Therapeutics Long — —
Log in to see ideas

About NKTR Investor Commentary

Across the available history and selected sources, Buzzberg tracks NKTR (Nektar Therapeutics) across 6 sources: 103 bullish vs 0 bearish calls from 5 authors. Historical directional balance: 51% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 202 total trade ideas tracked. Past 7 days, before deduplication: 1 bullish. Latest voices: crux_capital_, A May MD, seedy19tron.